Page results
-
Information about preparing for and undergoing surgery at University College London Hospitals NHS Foundation Trust.
-
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
UCLH is the first NHS trust to pilot a personalised educational package for patients living with stroke.
-
Christmas is an exciting time even if it will be a bit different for us all this year. We might be spending more time inside, making us less active than usual for this time of year. However, it is still a good time to relax and enjoy some Christmas treats.
-
Nine Covid-19 research studies are already taking place at UCLH and the Trust is processing more than 30 study proposals as research efforts around the virus and pandemic are ramped up.
-
This page explains what patient-initiated follow-up (PIFU) involves after your treatment for endometrial (uterine or womb) cancer.
-
Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.
-
Fiona Farrell works at the Sir William Gowers Unit, a specialist treatment centre for epilepsy and related disorders.
-
UCLH will play a vital role in a new respiratory virus study.
-
Urology services and thoracic surgery are now provided at University College Hospital at Westmoreland Street. Cardiac services have transferred from UCLH to the Barts Heart Centre at St Bartholomew’s Hospital, new services have moved into the hospital. The following services are based at the University College Hospital at Westmoreland Street: Thoracic Surgery Inpatient Stone Team Services (patients being admitted for operations) Robotic Surgery inpatients Andrology inpatients Male reconstructive inpatient surgery Adolescent urology inpatients Urological Cancer patients Functional restorative and female urology inpatients All urology outpatients clinics
File results
-
FOI/2022/0544 - Wards/ departments that provide services to 0-17 year-olds
-
FOI/2022/0545 - Criteria used in determining acceptance of GP referrals for osteoporosis treatment, and for priorisation of osteoporosis appointments
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis